In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Resbiotic Nutrition Inc. ("resbiotic" or "res"), a leading provider of physician-formulated and science-backed dietary supplements, has announced a strategic distribution agreement with Grupo Columbia ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

World’s First “Universal” Robotics Software Platform BOW Raises £4 Million Seed to Reduce Cost and Complexity of Programming ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...